← Back to Search

Other

GV101 for Clinical Trials

Phase 1
Waitlist Available
Research Sponsored by Graviton Bioscience Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 7.
Awards & highlights

Summary

This trial tests a new drug called GV101 in healthy individuals to see if it is safe and to understand how the body processes it. The study will help determine the right dosage by measuring how much of the drug gets into the bloodstream and how long it stays there.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 7.
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 7. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment emergent AEs

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Study drug: GV101Experimental Treatment1 Intervention
400 mg (10 mL liquid), 800 mg (20 mL liquid), 1600 mg (40mL liquid) of GVS101 will be administered once, orally to subjects in the treatment group, cohort 5 to 7.
Group II: PlaceboPlacebo Group1 Intervention
Matched placebo control 400 mg (10 mL liquid), 800 mg (20 mL liquid), 1600 mg (40mL liquid) of GVS101 will be administered once, orally to subjects in the control group, cohort 5 to 7.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GV101
2021
Completed Phase 1
~20

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Graviton Bioscience CorporationLead Sponsor
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top